Cytomegalovirus infection after liver transplantation: Viral load as a guide to treating clinical infection

Transplantation

Volumn 74, Issue 4, 2002, Pages 527-531

  Norris, Suzanne ^a   Kosar, Yasmin ^a   Donaldson, Nora ^b   Smith, Heather M ^a   Zolfino, Teresa ^a   O'Grady, John G ^a   Muiesan, Paolo ^a   Rela, Mohammed ^a   Heaton, Nigel ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b Institute of Psychiatry

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GANCICLOVIR; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS DNA;

ADULT; ALLOTRANSPLANTATION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; GRAFT REJECTION; HIGH RISK POPULATION; HUMAN; HYBRIDIZATION; INFECTION RISK; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RELIABILITY; RISK ASSESSMENT; TREATMENT PLANNING; VIRUS CULTURE; VIRUS LOAD;

EID: 0037183624     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200208270-00016     Document Type: Article

References (21)

1. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation
2. Cytomegalovirus infection after liver transplantation: Clinical manifestations and strategies for prevention
3. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis
4. CMV infection, class II antigen expression, and human kidney allograft rejection
5. Cytomegalovirus infection and donor/recipient HLA antigens: Interdependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation
6. Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome
7. An association between cytomegalovirus infection and chronic rejection after liver transplantation
8. Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients
9. Use of laboratory tests to predict cytomegalovirus disease in renal transplant recipients
10. Comparison of a new quantitative cytomegalovirus DNA assay with other detection methods
11. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver transplant recipients
12. Prophylactic oral ganciclovir compared to deferred therapy for control of cytomegalovirus in renal transplant recipients
13. Surveillance cultures of blood, urine, and throat specimens are not valuable for predicting cytomegalovirus disease in liver transplant recipients
14. The role of PCR in the diagnosis and management of CMV in solid organ recipients
15. Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation
16. A prospective study of the predictive value of polymerase chain reaction assay for cytomegalovirus in asymptomatic kidney transplant recipients
17. Cytomegalovirus pp65 antigenemia monitoring as a guide for preemptive therapy: A cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients
18. Detection of CMV matrix protein pp65 antigen in leucocytes by immunofluorescence as a marker of CMV disease
19. Evaluation of the murex hybrid capture DNA assay versus plasma PCR and the shell vial assay for the diagnosis of human cytomegalovirus viremia in immunocompromised patients
20. CMV viral load measurements in whole blood and plasma: Which is best following renal transplantation?
21. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation